Therapeutic Advances in Drug Safety: 2023, vol: 14, issue:
1)- Nokuthula L Makhene, Hanlie Steyn, Martine Vorster, Martie S Lubbe, Johanita R Burger. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.Therapeutic advances in drug safety. 2023, 14: 20420986221143272
2)- Marie-Celine Haker, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar, Jane Louisa Debus, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Uwe Klaus Zettl. Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy.Therapeutic advances in drug safety. 2023, 14: 20420986221143830
3)- Fiona Robinson, Sonji Wilkes, Nathan Schaefer, Miriam Goldstein, Michelle Rice, Johanna Gray, Sharon Meyers, Leonard A Valentino. Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community.Therapeutic advances in drug safety. 2023, 14: 20420986221146418
5)- Ali F Altebainawi, Lulwa A Alfaraj, Amjad A Alharbi, Fadwa F Alkhuraisi, Thamir M Alshammari. Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database.Therapeutic advances in drug safety. 2023, 14: 20420986231154075
6)- Fatema A Alqenae, Douglas Steinke, Andrew Carson-Stevens, Richard N Keers. Analysis of the nature and contributory factors of medication safety incidents following hospital discharge using National Reporting and Learning System (NRLS) data from England and Wales: a multi-method study.Therapeutic advances in drug safety. 2023, 14: 20420986231154365
7)- Charlotte Arp Sørensen, Linda Jeffery, Jannik Falhof, Philipp Harbig, Klaus Roelsgaard, Solveig Gram, Charlotte Olesen. Developing and piloting a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice.Therapeutic advances in drug safety. 2023, 14: 20420986231159221
8)- Heyde-Patricia Zuluaga-Arias, Mayada Alkhakany, Manal M Younus, Houda Sefiani, Angela Caro-Rojas, Sameh Al-Zubiedi, Wafi F Albalawi, Thamir M Alshammari. Impact of risk communication on patient's safety during the pandemic.Therapeutic advances in drug safety. 2023, 14: 20420986231159752
9)- Sara Eslait-Olaciregui, Kevin Llinás-Caballero, David Patiño-Manjarrés, Thomas Urbina-Ariza, Juan Fernando Cediel-Becerra, Camilo Alberto Domínguez-Domínguez. Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.Therapeutic advances in drug safety. 2023, 14: 20420986231165674
10)- Yang Lu, Caiyun Guo. Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients.Therapeutic advances in drug safety. 2023, 14: 20420986231178126
11)- Britney A Stottlemyer, Michael C McDermott, Mackenzie R Minogue, Matthew P Gray, Richard D Boyce, Sandra L Kane-Gill. Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study.Therapeutic advances in drug safety. 2023, 14: 20420986231181334
13)- Ivana Damnjanović, Nastia Tsyplakova, Nikola Stefanović, Tatjana Tošić, Aleksandra Catić-Đorđević, Vangelis Karalis. Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population.Therapeutic advances in drug safety. 2023, 14: 20420986231181337
14)- Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, Yu-Hung Kuo, Mann-Jen Hour. Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study.Therapeutic advances in drug safety. 2023, 14: 20420986231181338
15)- Opeyemi Atanda, Jonathan West, Tom Stables, Chris Johnson, Robert Merrifield, James Kinross. Flow rate accuracy of infusion devices within healthcare settings: a systematic review.Therapeutic advances in drug safety. 2023, 14: 20420986231188602
16)- Ambrose O Isah, Abimbola O Opadeyi, Henry Tumwijukye, Frank Cobelens, Diede Smith, Margareth Ndomondo-Sigonda, Linda Harmark, Paul Tanui, Edine Tiemersma, Blandina T Mmbaga, Gugu Mahlangu, Stephen A Ayinbuomwan, Rachida Soulaymani, Jayesh M Pandit. Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries.Therapeutic advances in drug safety. 2023, 14: 20420986231188836
17)- Lillian Asio, Marble Nasasira, Ronald Kiguba. Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors.Therapeutic advances in drug safety. 2023, 14: 20420986231188842
18)- Florian Schindler, Timo Schinkoethe, Sven Mahner, Thomas Kolben, Rachel Wuerstlein, Carsten Culmsee, Nadia Harbeck, Tanja K Eggersmann. Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers.Therapeutic advances in drug safety. 2023, 14: 20420986231188845
20)- Carlos-Alberto Calderon-Ospina. Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance.Therapeutic advances in drug safety. 2023, 14: 20420986231194754
21)- Yanping Li, Yuanlin Wu, Tingting Jiang, Haiyan Xing, Jing Xu, Chen Li, Rui Ni, Ni Zhang, Guiyuan Xiang, Li Li, Ziwei Li, Lanlan Gan, Yao Liu. Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature.Therapeutic advances in drug safety. 2023, 14: 20420986231200746
22)- Winter Roth, David Dadiomov, Michelle Chu. Inappropriate quetiapine use at a large academic medical center: frequency of misuse and associated costs of adverse effects.Therapeutic advances in drug safety. 2023, 14: 20420986231213173
23)- Yodit Fitsum, Azania Werede, Abubeker Mahmud Saleh, Eyasu H Tesfamariam, Francis Magombo, Freminatos Misghina, Hermella Yemane, Iyassu Bahta, Liya Abraham, Merhawi Bahta, Merhawi Debesai, Meron Tesfagaber, Michael Ghirmai, Sirak Tesfamariam, Mulugeta Russom. Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey.Therapeutic advances in drug safety. 2023, 14: 20420986231213713
24)- Charlotte Arp Sørensen, Linda Jeffery, Klaus Roelsgaard, Solveig Gram, Jannik Falhof, Philipp Harbig, Charlotte Olesen. Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice: a mixed methods study.Therapeutic advances in drug safety. 2023, 14: 20420986231213714
25)- Chenyang Xu, Rui Peng, Xiali Qian, Shanwu Feng, Hongmei Yuan. Modified Dixon sequential method to determine the effective dose of alfentanil compounded with propofol for day-case hysteroscopy.Therapeutic advances in drug safety. 2023, 14: 20420986231214992